Looking to bid on government tenders? See our TaaS tender preparation service
Tenders

Normal human immunoglobulin for intravenous administration

Open
Deadline
4 days left
August 17, 2026
Contract Details
Category
Other
Reference
PHARM-2026-845
Value
Not disclosed
Location
BE100, Belgium
Published
August 05, 2026
Organization
Département Pharmacie
CPV Code
Project Timeline

Tender Published

July 08, 2026

Deadline for Questions

August 10, 2026

Submission Deadline

August 17, 2026

View Original
Budget
Not disclosed
Duration
7 months
Location
BE100
Type
Other

Original Tender Description

Le marché concerne la fourniture d’immunoglobuline humaine normale pour administration intraveineuse à une concentration de 10%.

Risk Analysis

Risk analysis is not yet available for this country's tenders. Currently supported: Estonia, Latvia, Lithuania, Poland, France, UK, Denmark, Netherlands, Norway, and Finland.

Win Strategy

Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.

Login

Basic Requirements

  • Company registration in EU required
  • Proven track record in similar projects
  • Financial stability documentation

Documents

10 documents available with AI summaries

Avis de marché (publicprocurement.be)DOC

No summary available for this document.

espd-request.zipZIP
espd-request.zip

No summary available for this document.

PHARM-2026-845 Annexe A - Formulaire d'offre.docxDOC
PHARM-2026-845 Annexe A - Formulaire d'offre....

No summary available for this document.

PHARM-2026-845 Annexe B - Inventaire V02.xlsxXLS
PHARM-2026-845 Annexe B - Inventaire V02.xlsx

No summary available for this document.

PHARM-2026-845 Annexe C - Critères d'attribution.docxDOC
PHARM-2026-845 Annexe C - Critères d'attribut...

No summary available for this document.

PHARM-2026-845 Annexe D - Dispositions contractuelles.docxDOC
PHARM-2026-845 Annexe D - Dispositions contra...

No summary available for this document.

PHARM-2026-845 Annexe E - Exigences techniques.docxDOC
PHARM-2026-845 Annexe E - Exigences technique...

No summary available for this document.

PHARM-2026-845 Annexe F - Pouvoir de signature.pdfPDF
PHARM-2026-845 Annexe F - Pouvoir de signatur...

No summary available for this document.

PHARM-2026-845 Annexe G - Attestation bonne execution.docxDOC
PHARM-2026-845 Annexe G - Attestation bonne e...

No summary available for this document.

PHARM-2026-845 Immunoglobuline-Cahier des charges Vf.pdfPDF
PHARM-2026-845 Immunoglobuline-Cahier des cha...

No summary available for this document.

Documents Preview

Sign up to view document summaries and analysis

Quality Score

Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.

Login
✨Want us to handle this tender?Let's Win This Tender

Add to Pipeline